| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Dihydromyricetin | Diabetes Type 2 | 5 | PM | 38275711 | 📋 | The Molecular Mechanism Underlying the Therapeutic Effect of Dihydromyricetin on Type 2 Diabetes Mellitus Based on Network Pharmacology, Molecular Docking, and Transcriptomics |
| Dihydromyricetin | Diabetes Type 2 | 4 | PM | 29425256 | 📋 | Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice |
| Dihydromyricetin | Diabetes Type 2 | 3 | PM | 29160030 | 📋 | Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARγ in 3T3-L1 cells |
| Dihydromyricetin | Diabetes Type 2 | 2 | PM | 27391974 | 📋 | Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway |
| Dihydromyricetin | Diabetes Type 2 | 1 | PM | 26644014 | 📋 | Ampelopsin protects endothelial cells from hyperglycemia-induced oxidative damage by inducing autophagy via the AMPK signaling pathway |
| Dihydromyricetin | Hyperglycemia | 2 | PM | 35752009 | 📋 | Dihydromyricetin protects against high glucose-induced endothelial dysfunction: Role of HIF-1α/ROR2/NF-κB |
| Dihydromyricetin | Hyperglycemia | 1 | PM | 35635431 | 📋 | Dihydromyricetin improves high-fat diet-induced hyperglycemia through ILC3 activation via a SIRT3-dependent mechanism |
| Dihydromyricetin | Insulin Resistance | 5 | PM | 38532480 | 📋 | Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway |
| Dihydromyricetin | Insulin Resistance | 4 | PM | 34650665 | 📋 | Dihydromyricetin Ameliorates Inflammation-Induced Insulin Resistance via Phospholipase C-CaMKK-AMPK Signal Pathway |
| Dihydromyricetin | Insulin Resistance | 3 | PM | 31802924 | 📋 | Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice |
| Dihydromyricetin | Insulin Resistance | 2 | PM | 29160030 | 📋 | Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARγ in 3T3-L1 cells |
| Dihydromyricetin | Insulin Resistance | 1 | PM | 27391974 | 📋 | Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway |
| Dihydromyricetin | Metabolic Disorders | 3 | PM | 35247719 | 📋 | Recent update on application of dihydromyricetin in metabolic related diseases |
| Dihydromyricetin | Metabolic Disorders | 2 | PM | 33080338 | 📋 | Dihydromyricetin improves mitochondrial outcomes in the liver of alcohol-fed mice via the AMPK/Sirt-1/PGC-1α signaling axis |
| Dihydromyricetin | Metabolic Disorders | 1 | PM | 32071609 | 📋 | Metabolomics of the Protective Effect of Ampelopsis grossedentata and Its Major Active Compound Dihydromyricetin on the Liver of High-Fat Diet Hamster |
| Dihydromyricetin | Metabolic Syndrome | 2 | PM | 31802924 | 📋 | Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice |
| Dihydromyricetin | Metabolic Syndrome | 1 | PM | 31193933 | 📋 | Dihydromyricetin-rich herbal mixture extracts as a potential prescription for treatment of metabolic syndrome in rats fed a high-fat diet and subacute toxicity assessment in rats |
| Dihydromyricetin | Mitochondrial Dysfunction | 1 | PM | 30443190 | 📋 | SIRT3 Activation by Dihydromyricetin Suppresses Chondrocytes Degeneration via Maintaining Mitochondrial Homeostasis |
| Dihydromyricetin | Obesity | 5 | PM | 36283451 | 📋 | Dihydromyricetin contributes to weight loss via pro-browning mediated by mitochondrial fission in white adipose |
| Dihydromyricetin | Obesity | 4 | PM | 35690863 | 📋 | Dihydromyricetin ameliorates diet-induced obesity and promotes browning of white adipose tissue by upregulating IRF4/PGC-1α |
| Dihydromyricetin | Obesity | 3 | PM | 35147634 | 📋 | Dihydromyricetin prevents obesity via regulating bile acid metabolism associated with the farnesoid X receptor in ob/ ob mice |
| Dihydromyricetin | Obesity | 1 | PM | 33830233 | 📋 | Dihydromyricetin Imbues Antiadipogenic Effects on 3T3-L1 Cells via Direct Interactions with 78-kDa Glucose-Regulated Protein |
| Dihydromyricetin | Obesity | 2 | PM | 32476366 | 📋 | [Effects of dihydromyricetin on high fat diet induced obesity in mice and its mechanism] |
